Results of a systematic review study examining the efficacy of polatuzumab vedotin with rituixmab and bendamustine for relapsed DLBCL.
Home / Resource Library / A Systematic Review of the Clinical Efficacy of Treatments in Relapsed or Refractory Diffuse Large B Cell Lymphoma